What to Know About BCG Treatments for Bladder Cancer with Dr. Ashish Kamat

In Episode 37 of “Bladder Cancer Matters,” host Rick Bangs talks with two-time return guest Dr. Ashish Kamat. Dr. Kamat is a professor of urology and director of bladder cancer research at MD Anderson Cancer Center in Houston, Texas. He’s also a member of the Bladder Cancer Advocacy Network’s Scientific Advisory Board.

Rick and Dr. Kamat talk about what is on the mind of many bladder cancer patients: what to expect before, during and after BCG treatments for non muscle-invasive bladder cancer. They chat about:

• How BCG treatments work
• What patients can expect before treatment – is there any sort of prep required?
• What the treatment itself is like
• What patients and expect following a treatment, including side effects
• The “right” number of treatments, given that some patients are receiving fewer treatments because of COVID or the shortage

Dr. Kamat’s prior two Bladder Cancer Matters podcast episodes include:

• Episode 1, What’s Up with Bladder Cancer and BCG, with Dr. Ashish Kamat
• Episode 4, The Slippery Slope of Bladder Cancer, Staging and Radical Cystectomies with Dr. Ashish Kamat

Disclaimer: The views and opinions expressed in this podcast are those of the speakers and guests and do not necessarily reflect the views or positions of the Bladder Cancer Advocacy Network.